NAVB : Summary for Navidea Biopharmaceuticals, Inc - Yahoo Finance

U.S. Markets close in 5 hrs 8 mins

Navidea Biopharmaceuticals, Inc (NAVB)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.45+0.01 (+1.20%)
At close: 4:02PM EST
People also watch
IMUCMSTXGALECPRXCLSN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.44
Open0.43
Bid0.00 x
Ask0.00 x
Day's Range0.43 - 0.45
52 Week Range0.26 - 1.51
Volume359,132
Avg. Volume1,002,334
Market Cap69.23M
Beta-0.71
PE Ratio (TTM)-5.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire24 days ago

    Navidea to Hold Conference Call to Provide Investor Update on Status of Ongoing Corporate Events

    Navidea Biopharmaceuticals, Inc. today announced that management will hold an audio webcast conference call on Tuesday, January 31, 2017 at 4:30 p.m. to provide investor update on status of ongoing corporate events.

  • Business Wirelast month

    Navidea to Present at Upcoming Investor Conference

    Navidea Biopharmaceuticals, Inc. today announced that management will present at an upcoming investor conference. An audio webcast of the presentation will be available live at the URL links noted below.

  • Capital Cube2 months ago

    ETFs with exposure to Navidea Biopharmaceuticals, Inc. : December 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Navidea Biopharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to NAVB-US. Comparing the performance and risk of Navidea Biopharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)